Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier ...

Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages ...

Almirall has licensed an interleukin-2 (IL-2) drug from China's Simcere Pharma, joining the ranks of companies looking at blocking the cytokine as a way to treat autoimmune diseases.

BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM): Financial highlights (€ rounded million) "2024 was an important year for Almirall as European leader in Medical Dermatology: we delivered ...

(Reuters) - Spanish pharmaceutical company Almirall expects to almost double its annual revenue by 2030, boosted by higher sales of its dermatological products in Europe, CEO Carlos Gallardo said ...

Having been in development by Almirall and Eli Lilly and Company for moderate to severe AD, recent findings from a phase 3 trial for the first time have shown year-long (52-week) management of ...

Almirall´s strong presence at the AAD conference, sharing new data on Almirall’s dermatology and pipeline portfolio demonstrate its dedication to the medical community and patients living with ...

Jefferies analyst Lucy Codrington maintained a Buy rating on Almirall (0O9B – Research Report) yesterday and set a price target of €17.00. The ...

"2024 was an important year for Almirall as European leader in Medical Dermatology: we delivered impactful products to more patients and the medical community. Our double-digit sales growth and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16 th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology.